Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,037 public trials 564 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Recruiting

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

NCT05645107

Conditions
Agammaglobulinemia, B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, +25 more
Locations
  • GC2202 Study Site 115 Huntington Park, California, United States
  • GC2202 Study Site 103 St. Petersburg, Florida, United States
  • GC2202 Study Site 111 Bethesda, Maryland, United States
  • GC2202 Study Site 109 Greenville, North Carolina, United States
View all 62 locations
View Trial Details

Related conditions